Despesas De Vendas E Administração Alterar Data
AstraZeneca USD 4.07B 1.73B 2026-09
Genmab DKK 205M 39M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
GRIFOLS EUR 326M 37M 2026-09
Hikma Pharmaceutical USD 288M 149M 2025-12
Lakefront Biotherapeutics EUR 22.5M 13M 2026-06
Qiagen NV USD 142.33M 60K 2026-06
UCB EUR 1.47B 193M 2025-12